Targeting Transforming Growth Factor β to Enhance Cancer Immunotherapy
Excerpt
Human tumours have evolved intricate mechanisms to evade the immune system, either by avoiding recognition or by inhibiting and eliminating immune cells. [...]
Share and Cite
Hahn, T.; Akporiaye, E.T. Targeting Transforming Growth Factor β to Enhance Cancer Immunotherapy. Curr. Oncol. 2006, 13, 141-143. https://doi.org/10.3390/curroncol13040015
Hahn T, Akporiaye ET. Targeting Transforming Growth Factor β to Enhance Cancer Immunotherapy. Current Oncology. 2006; 13(4):141-143. https://doi.org/10.3390/curroncol13040015
Chicago/Turabian StyleHahn, T., and Emmanuel T. Akporiaye. 2006. "Targeting Transforming Growth Factor β to Enhance Cancer Immunotherapy" Current Oncology 13, no. 4: 141-143. https://doi.org/10.3390/curroncol13040015
APA StyleHahn, T., & Akporiaye, E. T. (2006). Targeting Transforming Growth Factor β to Enhance Cancer Immunotherapy. Current Oncology, 13(4), 141-143. https://doi.org/10.3390/curroncol13040015